Logo image of NOGN

NOGIN INC (NOGN) Stock Fundamental Analysis

NASDAQ:NOGN - Nasdaq - US65528N2045 - Common Stock - Currency: USD

0.061  -0.05 (-45.58%)

After market: 0.0526 -0.01 (-13.77%)

Fundamental Rating

1

Taking everything into account, NOGN scores 1 out of 10 in our fundamental rating. NOGN was compared to 32 industry peers in the Broadline Retail industry. NOGN has a bad profitability rating. Also its financial health evaluation is rather negative. NOGN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NOGN has reported negative net income.
In the past year NOGN has reported a negative cash flow from operations.
NOGN Yearly Net Income VS EBIT VS OCF VS FCFNOGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 0 -20M -40M

1.2 Ratios

The Return On Assets of NOGN (-82.25%) is worse than 97.06% of its industry peers.
Industry RankSector Rank
ROA -82.25%
ROE N/A
ROIC N/A
ROA(3y)-25.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NOGN Yearly ROA, ROE, ROICNOGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 0 200 -200 -400

1.3 Margins

Looking at the Gross Margin, with a value of 46.16%, NOGN is in the better half of the industry, outperforming 61.76% of the companies in the same industry.
In the last couple of years the Gross Margin of NOGN has declined.
NOGN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.25%
GM growth 5YN/A
NOGN Yearly Profit, Operating, Gross MarginsNOGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 0 20 -20 40 -40 60

More info and screens

0

2. Health

2.1 Basic Checks

NOGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NOGN remains at a similar level compared to 1 year ago.
The debt/assets ratio for NOGN is higher compared to a year ago.
NOGN Yearly Shares OutstandingNOGN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2M 4M 6M 8M 10M
NOGN Yearly Total Debt VS Total AssetsNOGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -7.66, we must say that NOGN is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of NOGN (-7.66) is worse than 82.35% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.66
ROIC/WACCN/A
WACC4.56%
NOGN Yearly LT Debt VS Equity VS FCFNOGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

A Current Ratio of 0.14 indicates that NOGN may have some problems paying its short term obligations.
With a Current ratio value of 0.14, NOGN is not doing good in the industry: 97.06% of the companies in the same industry are doing better.
NOGN has a Quick Ratio of 0.14. This is a bad value and indicates that NOGN is not financially healthy enough and could expect problems in meeting its short term obligations.
NOGN's Quick ratio of 0.06 is on the low side compared to the rest of the industry. NOGN is outperformed by 97.06% of its industry peers.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.06
NOGN Yearly Current Assets VS Current LiabilitesNOGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 10M 20M 30M 40M 50M

More info and screens

4

3. Growth

3.1 Past

NOGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.81%, which is quite impressive.
NOGN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -39.39%.
NOGN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 32.09% yearly.
EPS 1Y (TTM)25.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120.69%
Revenue 1Y (TTM)-39.39%
Revenue growth 3Y32.09%
Revenue growth 5YN/A
Sales Q2Q%-48.01%

3.2 Future

NOGN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.11% yearly.
Based on estimates for the next years, NOGN will show a small growth in Revenue. The Revenue will grow by 2.87% on average per year.
EPS Next Y88.6%
EPS Next 2Y41.4%
EPS Next 3Y26.11%
EPS Next 5YN/A
Revenue Next Year-42.53%
Revenue Next 2Y-10.49%
Revenue Next 3Y2.87%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NOGN Yearly Revenue VS EstimatesNOGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
NOGN Yearly EPS VS EstimatesNOGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NOGN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NOGN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NOGN Price Earnings VS Forward Price EarningsNOGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NOGN Per share dataNOGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

NOGN's earnings are expected to grow with 26.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.4%
EPS Next 3Y26.11%

More info and screens

0

5. Dividend

5.1 Amount

NOGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NOGIN INC

NASDAQ:NOGN (12/21/2023, 8:00:02 PM)

After market: 0.0526 -0.01 (-13.77%)

0.061

-0.05 (-45.58%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)11-22 2023-11-22/dmh
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners173.51%
Ins Owner Change0%
Market Cap688.60K
Analysts42.86
Price Target1.02 (1572.13%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-55.76%
Min EPS beat(2)-88.42%
Max EPS beat(2)-23.09%
EPS beat(4)1
Avg EPS beat(4)-47.28%
Min EPS beat(4)-88.42%
Max EPS beat(4)0.72%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.96%
Min Revenue beat(2)-16.37%
Max Revenue beat(2)-3.55%
Revenue beat(4)0
Avg Revenue beat(4)-10.35%
Min Revenue beat(4)-19.37%
Max Revenue beat(4)-2.13%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-60%
PT rev (3m)-60%
EPS NQ rev (1m)0%
EPS NQ rev (3m)45.79%
EPS NY rev (1m)-7.04%
EPS NY rev (3m)-7.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.5%
Revenue NY rev (1m)1.91%
Revenue NY rev (3m)1.91%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-6.12
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-3.34
FCFYN/A
OCF(TTM)-3.28
OCFYN/A
SpS6.05
BVpS-8.46
TBVpS-8.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -82.25%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.16%
FCFM N/A
ROA(3y)-25.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.25%
GM growth 5YN/A
F-Score4
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 65.24%
Cap/Sales 0.91%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.14
Quick Ratio 0.06
Altman-Z -7.66
F-Score4
WACC4.56%
ROIC/WACCN/A
Cap/Depr(3y)305.57%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.31%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120.69%
EPS Next Y88.6%
EPS Next 2Y41.4%
EPS Next 3Y26.11%
EPS Next 5YN/A
Revenue 1Y (TTM)-39.39%
Revenue growth 3Y32.09%
Revenue growth 5YN/A
Sales Q2Q%-48.01%
Revenue Next Year-42.53%
Revenue Next 2Y-10.49%
Revenue Next 3Y2.87%
Revenue Next 5YN/A
EBIT growth 1Y-59.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year48.07%
EBIT Next 3Y34.2%
EBIT Next 5YN/A
FCF growth 1Y-21.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.43%
OCF growth 3YN/A
OCF growth 5YN/A